depression on glp 1 Ozempic: GLP-1s Linked to 42% Lower Risk of Anxiety, Exploring the Side Effects of

: % of patients proceeded to surgery on schedule

Tirzepatide was non-inferior to dulaglutide in reducing CV events, supporting a CV benefit in people with type 2 diabetes (Nicholls et al, 2025)

Because it is administered via a weekly subcutaneous injection, the medication enters the bloodstream relatively quickly

Fibre Crucial for gut microbiome diversity and long-term metabolic health

Both contain the same ingredient, semaglutide, but Ozempic is FDA-approved for diabetes, and Wegovy is approved for weight management and cardiovascular protection in people with a history of heart disease

We were interested in examining the clinical practice prior to the implementation of the new guidelines to provide a baseline for comparison in future studies that may examine the impact of the ASA's 2023 guidance